Honeywell International Inc. (HON)

Honeywell International Inc. (HON) is trading at $227.64 as of November 11, 2026, above its 50-day and 200-day moving averages ($213.01 and $224.85), and the stock is well placed inside a range that has run from $186.76 to $252.00 over the past year. The main question for investors is whether the earnings record and the analysts' support can carry the shares toward the 52-week high, or whether slowing revenue will keep the gains modest. The most recent quarterly report, dated October 22, 2026, beat the EPS estimate by 5.09%, and the stock rose 1.67% in the first session afterward. Revenue still grew in that quarter, but only 1.30% year on year, which lags the sector median of 11.7%.

Honeywell has beaten the EPS estimate in all 8 of its recent reports, and it has never missed. The October 22, 2026 report came in at $2.27 against an estimate of $2.16, a beat of 5.09%, and the stock rose 1.67% in the first session afterward. The largest post-report move in its recent history was an advance of 6.81% after the October 23, 2025 report, which was also a beat of 9.94%. The record is not a guarantee of a rise, though. Three of the eight beats were followed by a lower share price in the first session, and the April 23, 2026 beat was followed by a fall of 2.56%. Investors have seen that beats do not lock in gains.

At a trailing P/E of 11.31, the stock trades at a discount to the Industrials median of 34.0, a gap of 66.7%. Its price-to-sales ratio of 1.91 is also half the sector median of 4.0. Return on equity of 44.39% is well above the sector median of 17.8%, and the net profit margin is 23.8%. Against that, revenue grew only 1.30% in the latest quarter year on year, which is 10.4 percentage points slower than the sector median of 11.7%. The low multiple therefore reflects slow top-line growth as much as it reflects any mispricing. Balance-sheet leverage is moderate, with a debt-to-equity ratio of 0.76.

The price is 6.87% above its 50-day average and 1.24% above its 200-day average, and the 50-day average is 5.27% below the 200-day average, which shows the stock has recovered from a weaker spring. The one-month return of 8.59% and the one-year return of 13.59% reflect that recovery. Of 24 analysts, 14 rate the stock buy or strong buy, 9 hold it and 1 sells it. On October 23, 2026, Citigroup, JP Morgan, Evercore ISI and RBC Capital each kept their ratings, and Mizuho and RBC Capital had done the same on October 15 and October 14. Three months earlier, 15 of the 24 ratings were buys, so the buy count has risen since then.

Insiders sold $22.8 million of stock over the last 18 months in 12 sales and made no open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they say little on their own about management's view of the business. The absence of insider buying does not signal a problem, but it also gives no support from that side.

The base case is that HON holds above its 200-day average and works toward the 52-week high, provided earnings keep beating estimates and revenue growth picks up from its current low pace. The analysts' median 12-month target of $254.00 sits about 11.6% above the price, and the target range runs from $186.00 to $290.00, so the spread of views is wide. Upside depends on revenue growth closing some of the gap to the sector and on analysts' forecast of 16.7% EPS growth next year being met. The main risk is that the expected 56.8% drop in this year's EPS and the 46.2% decline in expected revenue prove to be a sign of weaker top-line momentum, which would pull the price back toward the 200-day average and the 50-day average. This is an outline of conditions, not a forecast of returns.

Support sits first at $224.85, the 200-day simple moving average, which the price is currently just above. Below it is the 20-day exponential moving average at $220.64, which would be the next checkpoint in a pullback, followed by the 50-day simple moving average at $213.01. The lowest support is the 52-week low at $186.76. Resistance sits at the 52-week high of $252.00, the only level above the price, and it is close to the analysts' median target of $254.00.